Novartis Lamisil AT OTC Antifungal Said To Work In One Week
This article was originally published in The Tan Sheet
Executive Summary
Novartis said its new OTC athlete's foot medication Lamisil AT Cream is the only nonprescription medication that cures athlete's foot with one week of treatment in its announcement that FDA has approved the Rx-to-OTC switch.
You may also be interested in...
Schering-Plough’s “Faster” Claims For Lotrimin Ultra Not Accurate – NAD
Schering-Plough Healthcare Products should modify claims that its Lotrimin Ultra relieves athlete's foot in less time than Novartis Consumer Healthcare's Lamisil Defense, the National Advertising Division recommends
Schering-Plough’s “Faster” Claims For Lotrimin Ultra Not Accurate – NAD
Schering-Plough Healthcare Products should modify claims that its Lotrimin Ultra relieves athlete's foot in less time than Novartis Consumer Healthcare's Lamisil Defense, the National Advertising Division recommends
Schering-Plough’s “Faster” Claims For Lotrimin Ultra Not Accurate – NAD
Schering-Plough Healthcare Products should modify claims that its Lotrimin Ultra relieves athlete's foot in less time than Novartis Consumer Healthcare's Lamisil Defense, the National Advertising Division recommends